Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
Wolfgang R. Sperr(Medical University of Vienna), Peter Valent(Medical University of Vienna), Christian Baumgärtner(Graz University of Technology), Michael Pfeilstöcker(Hanusch Hospital), Thomas Nösslinger(Hanusch Hospital), A. Makrai(Hanusch Hospital), Reinhard Stauder(Innsbruck Medical University), Michael Kundi(Medical University of Vienna), O. Krieger(Krankenhaus der Elisabethinen), Friedrich Wimazal
Cited by 117
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496